Huarui Zheng

655 total citations
17 papers, 501 citations indexed

About

Huarui Zheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huarui Zheng has authored 17 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Huarui Zheng's work include RNA modifications and cancer (6 papers), RNA Research and Splicing (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). Huarui Zheng is often cited by papers focused on RNA modifications and cancer (6 papers), RNA Research and Splicing (5 papers) and Drug Transport and Resistance Mechanisms (2 papers). Huarui Zheng collaborates with scholars based in China and United States. Huarui Zheng's co-authors include Jiong Yang, Yuan Wang, Yuan Zhu, Eva Y.-H.P. Lee, Peng Zhang, Paul E. McKeever, Neha U. Patel, Dennis K. Burns, Lori Lowe and Yuan Zhu and has published in prestigious journals such as Cancer Cell, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Huarui Zheng

17 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huarui Zheng China 8 232 125 117 110 104 17 501
Shoju Hiraga Japan 13 364 1.6× 170 1.4× 175 1.5× 125 1.1× 122 1.2× 18 696
Romain Daveau France 11 226 1.0× 102 0.8× 103 0.9× 191 1.7× 104 1.0× 14 527
Zeng-jie Yang China 16 426 1.8× 159 1.3× 193 1.6× 49 0.4× 132 1.3× 51 757
José Lastiri Argentina 14 210 0.9× 204 1.6× 88 0.8× 34 0.3× 76 0.7× 22 539
Stacey Ivanchuk Canada 15 396 1.7× 177 1.4× 99 0.8× 37 0.3× 85 0.8× 19 712
Chibawanye Ene United States 7 346 1.5× 186 1.5× 256 2.2× 72 0.7× 162 1.6× 7 583
Jan Gronych Germany 11 466 2.0× 102 0.8× 308 2.6× 138 1.3× 138 1.3× 17 706
Barbara Costa Germany 13 228 1.0× 134 1.1× 81 0.7× 57 0.5× 60 0.6× 15 530
Tomoyuki Kawataki Japan 13 174 0.8× 116 0.9× 140 1.2× 50 0.5× 79 0.8× 22 485
Marcel van der Weiden Netherlands 14 252 1.1× 133 1.1× 157 1.3× 61 0.6× 120 1.2× 25 625

Countries citing papers authored by Huarui Zheng

Since Specialization
Citations

This map shows the geographic impact of Huarui Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huarui Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huarui Zheng more than expected).

Fields of papers citing papers by Huarui Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huarui Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huarui Zheng. The network helps show where Huarui Zheng may publish in the future.

Co-authorship network of co-authors of Huarui Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Huarui Zheng. A scholar is included among the top collaborators of Huarui Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huarui Zheng. Huarui Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Feinberg, Tamar Y., Huarui Zheng, Rui Liu, et al.. (2018). Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs. Developmental Cell. 47(2). 145–160.e6. 51 indexed citations
2.
Wang, Yuan, Jiong Yang, Huarui Zheng, et al.. (2009). Expression of Mutant p53 Proteins Implicates a Lineage Relationship between Neural Stem Cells and Malignant Astrocytic Glioma in a Murine Model. Cancer Cell. 15(6). 514–526. 196 indexed citations
3.
Zheng, Huarui, Neha U. Patel, Jiong Yang, et al.. (2008). Induction of abnormal proliferation by non-myelinating Schwann cells triggers neurofibroma formation. Cancer Research. 68. 2955–2955. 3 indexed citations
4.
Zheng, Huarui, Neha U. Patel, Jiong Yang, et al.. (2008). Induction of Abnormal Proliferation by Nonmyelinating Schwann Cells Triggers Neurofibroma Formation. Cancer Cell. 13(2). 117–128. 125 indexed citations
5.
Zheng, Huarui, Chaoneng Ji, Shaohua Gu, et al.. (2005). Cloning and characterization of a novel RNA polymerase II C-terminal domain phosphatase. Biochemical and Biophysical Research Communications. 331(4). 1401–1407. 27 indexed citations
6.
Li, Jixi, Chaoneng Ji, Huarui Zheng, et al.. (2005). Molecular cloning and characterization of a novel human gene containing 4 ankyrin repeat domains.. Cellular & Molecular Biology Letters. 10(1). 185–93. 4 indexed citations
7.
Zou, Xianqiong, Dianzuo Wang, Guanzhou Qiu, et al.. (2005). Molecular Cloning and Characterization of a Novel Human C4orf13 Gene, Tentatively a Member of the Sodium Bile Acid Cotransporter Family. Biochemical Genetics. 43(3-4). 165–173. 6 indexed citations
8.
Li, Jixi, Huarui Zheng, Chaoneng Ji, et al.. (2005). A novel splice variant of humanXRN2gene is mainly expressed in blood leukocyte. DNA sequence. 16(2). 143–146. 3 indexed citations
9.
Zou, Xianqiong, Guanzhou Qiu, Chunjing Chen, et al.. (2005). Expression pattern and subcellular localization of five splice isoforms of human PXK.. PubMed. 16(4). 701–7. 7 indexed citations
10.
Wu, Maoqing, Shaohua Gu, Xianqiong Zou, et al.. (2005). A novel splice variant of human geneNPL, mainly expressed in human liver, kidney and peripheral blood leukocyte. DNA sequence. 16(2). 137–142. 6 indexed citations
11.
Zheng, Huarui, Chaoneng Ji, Jixi Li, et al.. (2004). Cloning and Analysis of Human Apg16L. DNA sequence. 15(4). 303–305. 25 indexed citations
12.
Zou, Xianqiong, Liu Wang, Maoqing Wu, et al.. (2004). Molecular Cloning and Characterization ofSGT1.2, a Novel Splice Variant ofHomo sapiens SGT1. DNA sequence. 15(2). 140–143. 3 indexed citations
13.
Zheng, Huarui, Yao Li, Jixi Li, et al.. (2004). Characterization of a cDNA encoding a protein with limited similarity to β1, 3-N-acetylglucosaminyltransferase. Molecular Biology Reports. 31(3). 171–175. 3 indexed citations
14.
Zou, Xianqiong, Chaoneng Ji, Feng Jin, et al.. (2004). Cloning, characterization and expression of CDK5RAP1.UPSILON.3 and CDK5RAP1.UPSILON.4, two novel splice variants of human CDK5RAP1. Genes & Genetic Systems. 79(3). 177–182. 6 indexed citations
15.
Wu, Maoqing, Li Yao, Chaoneng Ji, et al.. (2004). Cloning and Identification of a Novel Human GenePDLIM5, a Homolog of AD-associated Neuronal Thread Protein (AD7c-NTP). DNA sequence. 15(2). 144–147. 12 indexed citations
16.
Zheng, Huarui, Chaoneng Ji, Xianqiong Zou, et al.. (2003). Molecular Cloning and Characterization of a Novel Human Putative Transmembrane Protein Homologous to Mouse Sideroflexin Associated with Sideroblastic Anemia. DNA sequence. 14(5). 369–373. 16 indexed citations
17.
Wu, Maoqing, Chaoneng Ji, Jian Xu, et al.. (2003). A novel splice variant of human gene GDPD1 is mainly expressed in human ovary and small intestine. International Journal of Molecular Medicine. 12(6). 1003–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026